Trinity Capital Inc. quarterly report, Q2 FY2022

Full document

Trinity Capital Inc. — Q2 2022 Form 10-Q

Reporting period: Quarter and six months ended June 30, 2022. Trinity Capital is an internally managed business development company (BDC) focused on lending and equipment financing to growth-stage, often venture-backed, companies. Unless otherwise noted, amounts below are in U.S. dollars.

Financial and portfolio highlights

  • Investment income: Q2 total investment income was $33.5 million, up from $19.5 million a year earlier; first-half income was $65.3 million versus $36.8 million. Management attributed the increase mainly to a larger income-producing debt portfolio and higher stated interest income and OID/EOT accretion.
  • Net investment income: Q2 was $15.7 million ($0.51 per basic share), compared with $10.1 million ($0.38 per share) in Q2 2021. First-half net investment income was $31.3 million ($1.07 per basic share), versus $17.3 million ($0.69 per share).
  • Operating results and valuation: Q2 operations produced a $7.7 million decrease in net assets, versus a $24.7 million increase in Q2 2021. First-half operations produced a $16.8 million decrease, versus a $50.0 million increase a year earlier. The first-half result included $91.1 million of net unrealized investment depreciation, partly offset by $43.0 million of net realized gains. Q2 net realized investment losses were $9.6 million and net unrealized depreciation was $13.8 million.
  • Assets and NAV: At June 30, total assets were $1.090 billion, investments at fair value were $1.051 billion, liabilities were $631.8 million and net assets were $458.3 million. NAV was $14.62 per share, down from $16.40 at December 31, 2021. Shares outstanding rose to 31.36 million from 27.23 million at year-end, including shares issued in an April public offering.
  • Portfolio: Fair value increased to $1.051 billion from $873.5 million at year-end; the portfolio covered 108 companies versus 94. Secured loans and equipment financings represented 73.2% and 21.4% of investment fair value, respectively. Manufacturing and professional, scientific and technical services were the largest industry exposures, at 25.4% and 24.3%. The ten largest portfolio companies represented 31.3% of investment fair value.
  • Credit quality: Loans to three companies and equipment financing to one company were on non-accrual, with $20.5 million cost and $5.9 million fair value. Non-accrual investments were 0.6% of debt investment fair value, compared with 0.7% at year-end. The debt portfolio’s average internal risk rating remained 3.0.
  • Cash flow and liquidity: First-half operating cash use was $195.7 million, primarily reflecting investment purchases; financing provided $162.2 million, including $60.4 million from common-stock issuance and net credit-facility borrowings. Cash and cash equivalents were $13.2 million at June 30, down from $31.7 million at year-end; there was no restricted cash. KeyBank facility availability was approximately $80.0 million, and management said cash plus available borrowings should meet near-term investing and operating needs.
  • Debt and coverage: Debt principal outstanding totaled $595 million at June 30, including $220 million under the KeyBank facility and $375 million of notes (2025, August 2026, December 2026 and convertible). Total debt was $466 million at year-end. Asset coverage was approximately 177.1%, down from 195.8%; the filing reports the statutory minimum as 150%.
  • Distributions: The company declared a Q2 quarterly distribution of $0.42 per share and a supplemental $0.15 per share, payable July 15. The filing states distributions are at the Board’s discretion and depend on earnings, financial condition and other factors.

Material changes versus comparable periods

  • Higher investment income and net investment income reflected portfolio growth, but investment valuation losses drove a shift from positive operating results in 2021 to operating decreases in both Q2 and the first half of 2022.
  • Investment fair value grew while NAV per share declined. First-half net unrealized depreciation included significant valuation losses and reclassifications related to realized gains from investment exits; the filing also reports a $9.6 million Q2 realized loss, including a substantial affiliate-investment loss.
  • Interest expense and other debt financing costs increased to $7.8 million in Q2 and $14.6 million in the first half, from $4.4 million and $9.0 million, respectively, primarily due to increased KeyBank facility borrowings. Total debt rose by $129 million from year-end.
  • After quarter-end, Trinity issued an additional $57.5 million principal amount of 2025 Notes, bringing that series to $182.5 million outstanding; the notes began trading as TRINL on July 29, 2022.

Outlook, commentary and risks

  • The filing provides no quantified earnings, portfolio growth or distribution guidance. Management describes near-term liquidity as adequate, but future distributions remain discretionary.
  • About 99.7% of investments by fair value were Level 3, relying on significant unobservable valuation inputs. The filing cautions that estimated fair values may differ materially from realizable values.
  • Interest-rate exposure is two-sided: about 64.4% of debt investments by principal were floating-rate, while the KeyBank facility also carries a floating rate. The company estimated an annualized $4.1 million increase in net income for a 100-basis-point rate increase, assuming no change in portfolio or borrowing structure; rate floors make decreases asymmetric.
  • Management identifies credit, liquidity, valuation, leverage, growth-company performance, market volatility, inflation, interest rates, regulation and geopolitical conditions—including the Russia-Ukraine conflict—as risks. Borrowers may need additional capital to fund operations and service debt.
  • As of June 30, there were no outstanding unfunded investment commitments and no material legal proceedings disclosed. The company reported compliance with its debt covenants and effective disclosure controls.

Key facts for investors to verify

  • How much of the $91.1 million first-half unrealized depreciation reflects durable borrower deterioration versus market-yield or valuation-method changes, and whether further marks followed quarter-end.
  • The status and recovery outlook for the four non-accrual exposures, especially given their $20.5 million cost versus $5.9 million fair value.
  • Whether investment income and cash collections can sustain distributions as debt expense, leverage and share count increase; compare recurring cash income with OID/EOT accretion and one-time fees.
  • Current KeyBank borrowing availability, asset coverage and covenant headroom after the subsequent $57.5 million 2025 Notes issuance.
  • The basis for the large first-half realized gains alongside significant unrealized depreciation, including investment-sale proceeds, reclassification effects and affiliate-investment losses.